Tofacitinib Does Not Impair Sperm Quality in Men With Ulcerative Colitis.

Grosen, Anne; Bellaguarda, Emanuelle; Liljeqvist-Soltic, Ingela; Skytte, Anne-Bine; Hanauer, Stephen B; Kelsen, Jens

Grosen, Anne; Bellaguarda, Emanuelle; Liljeqvist-Soltic, Ingela; Skytte, Anne-Bine; Hanauer, Stephen B; Kelsen, Jens.

Afiliación

Grosen A; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
Bellaguarda E; Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Liljeqvist-Soltic I; Reproductive Medicine Centre, Skaane University Hospital, Malmoe, Sweden.
Skytte AB; Cryos International, Aarhus, Denmark.
Hanauer SB; Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Kelsen J; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Inflamm Bowel Dis ; 2024 Aug 23.

Article en En | MEDLINE | ID: mdl-39177988

We demonstrate that tofacitinib does not adversely affect semen quality or sex hormones in male patients. These first postmarketing data for tofacitinib and semen quality are reassuring. Our study raises no safety concerns, though larger studies are needed to confirm our findings.

Palabras clave

male fertility; sperm DNA integrity; sperm quality; tofacitinib; ulcerative colitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Inflamm Bowel Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google